A case report on efficacy of Abound™ for anti-EGFR antibody-associated skin disorder in metastatic colon cancer

BACKGROUND: Panitumumab is a full human epidermal growth factor receptor (EGFR) monoclonal antibody, an agent for metastatic colorectal cancer therapy. One of the most general adverse events of anti-EGFR monoclonal antibody therapy is skin disorder. At the present time, although prophylaxis of skin...

詳細記述

保存先:
書誌詳細
主要な著者: Matsuhashi, Nobuhisa, Takahashi, Takao, Nonaka, Kenichi, Ichikawa, Kengo, Yawata, Kazunori, Tanahashi, Toshiyuki, Imai, Hisashi, Sasaki, Yoshiyuki, Tanaka, Yoshihiro, Okumura, Naoki, Yamaguchi, Kazuya, Osada, Shinji, Yoshida, Kazuhiro
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2014
主題:
Case Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922949/
https://ncbi.nlm.nih.gov/pubmed/24517087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-12-35
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料